Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Circulation

• Publication date

  1982-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/01.CIR.65.1.202PMID 7053283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].

  1981cited by this paper
• HAEMODYNAMIC EFFECTS OF SULPHINPYRAZONE IN EXPERIMENTAL MYOCARDIAL ISCHAEMIA

  1981cited by this paper
• The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study.

  1980cited by this paper
• Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man.

  1980cited by this paper
• Sulphinpyrazone and warfarin: a probable drug interaction.

  1980cited by this paper
• Potentiation of warfarin action by sulphinpyrazone.

  1980cited by this paper
• Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

  1980cited by this paper
• Potentiation of coumarin effect by sulfinpyrazone.

  1979cited by this paper
• Possible interaction of sulfinpyrazone with coumarins.

  1978cited by this paper
• Further characterization of specific drug binding sites on human serum albumin.

  1976cited by this paper
• Studies on the optical enantiomorphs of warfarin in man.

  1974cited by this paper
• Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

  1974cited by this paper
• Interaction of sodium warfarin and disulfiram (antabuse) in man.

  1973cited by this paper
• Absolute configurations of the four warfarin alcohols.

  1972cited by this paper
• THE METABOLIC FATE OF WARFARIN: STUDIES ON THE METABOLITES IN PLASMA *

  1971cited by this paper
• Properties of 3-(1-Phenyl-Propyl)-4-Oxycoumarin (Marcoumar®) in the Plasma when Tested in Normal Cases and under the Influence of Drugs

  1968cited by this paper
• Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose

  1968cited by this paper
• STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

  1963cited by this paper
• Studies on the 4-Hydroxycoumarins. XVII.1a The Resolution and Absolute Configuration of Warfarin1b

  1961cited by this paper
• Information and error : an introduction to statistical analysis

  1959cited by this paper

• Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach

  2017cites this paper
• Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes

  2014cites this paper
• DMD058602 1379..1391

  2014influential citation
• Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure

  2013cites this paper
• In Vivo Information-Guided Prediction Approach for Assessing the Risks of Drug-Drug Interactions Associated with Circulating Inhibitory Metabolites

  2012cites this paper
• Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities

  2012cites this paper
• Are Circulating Metabolites Important in Drug–Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory Potency

  2011cites this paper
• The effect of bucolome, a CYP2C9 inhibitor, on the pharmacokinetics of losartan.

  2008cites this paper
• Systematic overview of warfarin and its drug and food interactions.

  2005cites this paper
• Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol

  2004cites this paper
• A Bayesian Method Based on Clotting Factor Activity for the Prediction of Maintenance Warfarin Dosage Regimens

  2003cites this paper
• No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients

  2002cites this paper
• The Stereoselective Effects of Bucolome on the Pharmacokinetics and Pharmacodynamics of Racemic Warfarin

  2001cites this paper
• Evaluation of Effects of Terbinafine on Single Oral Dose Pharmacokinetics and Anticoagulant Actions of Warfarin in Healthy Volunteers

  1997cites this paper
• CHAPTER 2 – Drug Interactions with Agents Used in the Treatment of Cardiovascular Disease

  1997cites this paper
• Stereochemical Aspects of Drug Action and Disposition

  1996cites this paper
• Multiple doses of trandolapril do not affect warfarin pharmacodynamics.

  1995cites this paper
• Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.

  1995cites this paper
• Adverse Interactions Between Warfarin and Nonsteroidal Antiinflammatory Drugs: Mechanisms, Clinical Significance, and Avoidance

  1995cites this paper
• Interactions of Warfarin with Drugs and Food

  1994cites this paper
• Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults

  1993cites this paper
• Stereoisomers and Drug Toxicity

  1993cites this paper
• Model to Detect Warfarin-Drug Interactions in Man

  1992cites this paper
• Prediction of the clinical efficacy of and intolerance to antirheumatic drug therapy

  1991cites this paper
• Molecular asymmetry and its pharmacological consequences.

  1991cites this paper
• Selective inhibition of warfarin metabolism by diltiazem in humans.

  1991cites this paper
• Enantiomer specific pharmacokinetics.

  1990cites this paper
• Cimetidine-nicoumalone interaction in man: stereochemical considerations.

  1989cites this paper
• Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.

  1989cites this paper
• Warfarin usage: can safety be improved?

  1989cites this paper
• Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout

  1989cites this paper
• Interactions of non-steroidal anti-inflammatory drugs.

  1988cites this paper
• Stereoselectivity: An Issue of Significant Importance in Clinical Pharmacology

  1988cites this paper
• Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

  1987cites this paper
• The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans

  1987cites this paper
• Bioavailability of warfarin in a patient with severe short bowel syndrome.

  1986cites this paper
• The warfarin‐sulfinpyrazone interaction: stereochemical considerations

  1986cites this paper
• Pharmacokinetic parameters obtained with racemates

  1986cites this paper
• Current concepts of warfarin therapy.

  1986cites this paper
• Stereoselective interaction between the R enantiomer of warfarin and cimetidine.

  1986cites this paper
• Anticoagulants in the treatment of cardiovascular disease

  1985cites this paper
• Importance of Drug Enantiomers in Clinical Pharmacology

  1985cites this paper
• Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.

  1985cites this paper
• Influence of cimetidine, sulfinpyrazone, and cigarette smoking on theobromine metabolism in man.

  1985cites this paper
• Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone.

  1984cites this paper
• Human cytochromes P-450.

  1984cites this paper
• Warfarin—sulfinpyrazone interaction on binding to human serum albumin

  1984cites this paper
• Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.

  1984cites this paper
• Determinants of acetaminophen metabolism: Effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways

  1984cites this paper
• Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.

  1983cites this paper
• Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.

  1982cites this paper